Evidence map›Paper›PMID 34112773›Full record

SynthesisNature communications2021

A meta-analysis of epigenome-wide association studies in Alzheimer's disease highlights novel differentially methylated loci across cortex.

Rebecca G Smith, Ehsan Pishva, Gemma Shireby, Adam R Smith, Janou A Y Roubroeks, Eilis Hannon, Gregory Wheildon, Diego Mastroeni, Gilles Gasparoni, Matthias Riemenschneider and 18 more

Open access · goldAbstract readMeta-Analysis
In one paragraph

Synthesis in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 112 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
112citing papers in PubMed, 7 pooled it
9.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

112 citing papers in PubMed, 7 syntheses or guidelines pooled it, 165 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Article
  9. Article
  10. Article
  11. Review
  12. Blood DNA Methylation Predicts Long-Term Risk of Dementia in Prospective Cohorts.medRxiv : the preprint server for health sciences · 2026
    Article
  13. Article
  14. Article
  15. Functional Genomics Studies of Psychiatric Disorders in Individuals of Latin American Populations: A Scoping Review.American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics · 2026
    Article
  16. Review
  17. Prediction of cognitive outcome and progression to dementia using ω6-PUFA/ω3-PUFA ratio.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  18. Article
  19. Article
  20. Article

52 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 14 institutions in 4 countries.

Rebecca G Smith *University of Exeter Medical School, College of Medicine and Health, University of Exeter, Exeter, UK.
Ehsan Pishva *University of Exeter Medical School, College of Medicine and Health, University of Exeter, Exeter, UK.ORCID 0000-0002-8964-0682
Gemma ShirebyUniversity of Exeter Medical School, College of Medicine and Health, University of Exeter, Exeter, UK.
Adam R SmithUniversity of Exeter Medical School, College of Medicine and Health, University of Exeter, Exeter, UK.ORCID 0000-0001-6495-2711
Janou A Y RoubroeksUniversity of Exeter Medical School, College of Medicine and Health, University of Exeter, Exeter, UK.
Eilis HannonUniversity of Exeter Medical School, College of Medicine and Health, University of Exeter, Exeter, UK.ORCID 0000-0001-6840-072X
Gregory WheildonUniversity of Exeter Medical School, College of Medicine and Health, University of Exeter, Exeter, UK.
Diego MastroeniBanner ASU Neurodegenerative Research Center, Biodesign Institute, Arizona State University, Tempe, AZ, USA.ORCID 0000-0001-5878-9372
Gilles GasparoniDepartment of Genetics, University of Saarland (UdS), Saarbruecken, Germany.ORCID 0000-0002-6423-4637
Matthias RiemenschneiderDepartment of Psychiatry and Psychotherapy, Saarland University Hospital (UKS), Homburg, Germany.
Armin GieseCenter for Neuropathology and Prion Research, Ludwig-Maximilians-University (LMU), Munich, Germany.
Andrew J SharpDepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID 0000-0003-1415-5129
Leonard SchalkwykSchool of Biological Sciences, University of Essex, Colchester, UK.ORCID 0000-0001-7030-5756
Vahram HaroutunianDepartment of Psychiatry, The Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID 0000-0001-5860-2512
Wolfgang ViechtbauerDepartment of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience (MHeNS), Maastricht University, Maastricht, The Netherlands.ORCID 0000-0003-3463-4063
Daniel L A van den HoveDepartment of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience (MHeNS), Maastricht University, Maastricht, The Netherlands.
Michael WeedonUniversity of Exeter Medical School, College of Medicine and Health, University of Exeter, Exeter, UK.
Danielle BrokawBanner ASU Neurodegenerative Research Center, Biodesign Institute, Arizona State University, Tempe, AZ, USA.
Paul T FrancisUniversity of Exeter Medical School, College of Medicine and Health, University of Exeter, Exeter, UK.
Alan J ThomasInstitute of Neuroscience, Newcastle University, Newcastle Upon Tyne, UK.
Seth LoveDementia Research Group, Institute of Clinical Neurosciences, School of Clinical Sciences, University of Bristol, Bristol, UK.
Kevin MorganHuman Genetics Group, University of Nottingham, Nottingham, UK.ORCID 0000-0002-8217-2396
Jörn WalterDepartment of Genetics, University of Saarland (UdS), Saarbruecken, Germany.ORCID 0000-0003-0563-7417
Paul D ColemanBanner ASU Neurodegenerative Research Center, Biodesign Institute, Arizona State University, Tempe, AZ, USA.
David A BennettRush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, USA.
Philip L De JagerCenter for Translational and Computational Neuroimmunology, Department of Neurology and Taub Institute, Columbia University Medical Center, New York, NY, USA.ORCID 0000-0002-8057-2505
Jonathan MillUniversity of Exeter Medical School, College of Medicine and Health, University of Exeter, Exeter, UK.ORCID 0000-0003-1115-3224
Katie LunnonUniversity of Exeter Medical School, College of Medicine and Health, University of Exeter, Exeter, UK. k.lunnon@exeter.ac.uk.ORCID 0000-0001-7570-6065
University of Exeter · GBArizona State University · USSaarland University · DEBroad Institute · USIcahn School of Medicine at Mount Sinai · USJames J. Peters VA Medical Center · USLudwig-Maximilians-Universität München · DEMaastricht University · NLNewcastle University · GBRush University Medical Center · USUniversity of Bristol · GBUniversity of Essex · GBUniversity of Nottingham · GBUniversity of Würzburg · DE

Funding

SUPPLEMENT TO RUSH ALZHEIMERS DISEASE CENTER COREP30AG010161 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 1991 to 2020
$49.1M
EPIDEMIOLOGY OF NEURAL RESERVE AND NEUROBIOLOGY IN AGINGR01AG017917 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 2001 to 2023
$43.3M
Research Education ComponentP30AG019610 · NIA · SUN HEALTH RESEARCH INSTITUTE · PI REIMAN, ERIC MICHAEL · 2001 to 2020
$32.5M
RISK FACTORS, PATHOLOGY, AND CLINICAL EXPRESSIONS OF ADR01AG015819 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 1998 to 2024
$21.4M
Exploring the Role of the Brain Epigenome: Cognitive Decline and Life ExperiencesRF1AG036042 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN, DE JAGER, PHILIP L · 2016 to 2016
$5.5M
Exploring the Role of the Brain Epigenome: Cognitive Decline and Life ExperiencesR01AG036042 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 2009 to 2013
$4.1M
DNA methylation in Alzheimer?s disease and normally aged brainR01AG036400 · NIA · BANNER SUN HEALTH RESEARCH INSTITUTE · PI COLEMAN, PAUL D · 2009 to 2013
$2.0M
A multi-faceted approach to epigenomic profiling in Alzheimer's disorderR01AG036039 · NIA · KING'S COLLEGE LONDON · PI MILL, JONATHAN · 2009 to 2012
$1.7M
A multi-omic approach to elucidate novel disease mechanisms and biomarkers for psychosis in Alzheimer’s diseaseR01AG067015 · NIA · UNIVERSITY OF EXETER · PI KOFLER, JULIA K, LUNNON, KATIE · 2019 to 2023
$1.6M
Medical Research Council G0400074Medical Research Council G0502157Medical Research Council G0900652Medical Research Council G1100540Medical Research Council M008924Medical Research Council MC_PC_14095Medical Research Council MC_PC_18025Medical Research Council MC_PC_20032Medical Research Council MR/M008924/1Medical Research Council MR/M024784/1Medical Research Council MR/N027973/1NIA NIH HHS P30 AG010161NIA NIH HHS P30 AG019610NIA NIH HHS R01 AG015819NIA NIH HHS R01 AG017917NIA NIH HHS R01 AG036039NIA NIH HHS R01 AG036042NIA NIH HHS R01 AG036400NIA NIH HHS R01 AG067015NIA NIH HHS RF1 AG036042
6 · The paper itself

Abstract

Epigenome-wide association studies of Alzheimer's disease have highlighted neuropathology-associated DNA methylation differences, although existing studies have been limited in sample size and utilized different brain regions. Here, we combine data from six DNA methylomic studies of Alzheimer's disease (N = 1453 unique individuals) to identify differential methylation associated with Braak stage in different brain regions and across cortex. We identify 236 CpGs in the prefrontal cortex, 95 CpGs in the temporal gyrus and ten CpGs in the entorhinal cortex at Bonferroni significance, with none in the cerebellum. Our cross-cortex meta-analysis (N = 1408 donors) identifies 220 CpGs associated with neuropathology, annotated to 121 genes, of which 84 genes have not been previously reported at this significance threshold. We have replicated our findings using two further DNA methylomic datasets consisting of a further >600 unique donors. The meta-analysis summary statistics are available in our online data resource ( www.epigenomicslab.com/ad-meta-analysis/ ).

Indexed as

DNA MethylationEpigenomeAgedAged, 80 and overAlzheimer DiseaseCohort StudiesCpG IslandsEntorhinal CortexEpigenesis, GeneticFemaleGenome-Wide Association StudyHumansMaleMiddle AgedPrefrontal CortexROC Curve

Identifiers

PMID34112773
PMCPMC8192929
OpenAlexW3168596946

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.